Company intelligence / Profile preview

NeuCyte

Mountain View, California, United Statesneucyte.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

NeuCyte develops proprietary human neural cell platforms to accelerate CNS drug discovery. Their SynFire® technology enables translatable phenotypic assays using patient-derived iPSC neurons to model neurological diseases. The company has received NIH funding to develop a microfluidics-based high-throughput screening system for Alzheimer's disease. No clinical results or late-stage assets are reported; the focus remains preclinical.

Therapeutic areas: Neurology
Modalities: iPSC-derived cell-based assays and platforms for drug discoveryPhenotypic screening using human neural cells
Industry: Drug Discovery Services

Drug pipeline

1 asset

NC-202

Pre-clinical

Indications: Epilepsy

Partnerships

University of California at San Francisco (UCSF) – NIH STTR grant collaborationAcoustic Bio – microfluidics/drug-screening partnershipMount Sinai Health System – collaboration agreement

Beyond the preview

Go deeper on NeuCyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuCyte.

Explore the full profile